Sort
1,049,261 grants matching “t cell”
Pannexin Channels In Vascular Physiology & Inflammation
$2,378,927Kodi S Ravichandran · University Of Virginia · P01 · FY2017 · HL
Pannexin channels in vascular physiology and inflammation
$2,378,927Kodi S Ravichandran · University Of Virginia · P01 · FY2014 · HL
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
$2,378,848Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · P01 · FY2021 · AI
Pathogenesis and management of heparin-induced thrombocytopeneia
$2,378,672Mortimer Poncz · Children'S Hosp Of Philadelphia · P01 · FY2012 · HL
Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity
$2,378,661Arjun Deb · University Of California Los Angeles · R01 · FY2023 · DK
Center for Pediatric Research
$2,378,568David A Pearce · Sanford Research/Usd · P20 · FY2014 · GM
The Cancer Cell Map Initiative v2.0
$2,378,309Nevan J Krogan · University Of California, San Francisco · U54 · FY2025 · CA
Neuroactive steroids as novel psychiatric treatments: mechanistic studies
$2,378,256Steven J Mennerick · Washington University · P50 · FY2025 · MH
National Longitudinal Survey of Youth: Older Children
$2,378,238Elizabeth C. Cooksey · Ohio State University · R01 · FY2020 · HD
Support for Toxicological Data for the National Toxicology Program Subproject 3 (Support for Biomedical Information Research by NTP)
$2,378,217Lisa Lopez · Vistronix, Inc. · N01 · FY2020 · ES
INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS
$2,378,051Massachusetts General Hospital · P01 · FY2004 · CA
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
$2,377,848Cesar Augusto Arias · Methodist Hospital Research Institute · P01 · FY2025 · AI
Mali Project (Serefo)
$2,377,836Sophia Siddiqui · National Institute Of Allergy And Infectious Diseases · ZID · FY2009 · AI
New Approaches to Inducing Cardiac Allograft Tolerance
$2,377,801Joren C Madsen · Massachusetts General Hospital · P01 · FY2024 · HL
Mucosal Immunity and Inflammatory Disease
$2,377,783Niki Moutsopoulos · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Tumor Cell Networks Center
$2,377,753Douglas A Lauffenburger · Massachusetts Institute Of Technology · U54 · FY2014 · CA
PATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS" CHARLES RIVER LABORATORIES (CRL)
$2,377,600James Morrison · Charles River Laboratories Intntl, Inc. · N01 · FY2023 · ES
A common denominator of pathogenesis; a rare opportunity for novel therapeutic de
$2,377,500Douglas Alan Mitchell · University Of Illinois At Urbana-Champaign · DP2 · FY2011 · OD
Defining the resident mesenchymal stem cell niche and function in vivo
$2,377,500Tien Peng · University Of California, San Francisco · DP2 · FY2016 · AG
Reconstructing dynamic epigenetic genome partitioning in single stem cells
$2,377,500Bassem Al-Sady · University Of California, San Francisco · DP2 · FY2016 · GM
Coordinate regulation of neural circuit remodeling by glia: a prospective molecular approach
$2,377,500Anna V Molofsky · University Of California, San Francisco · DP2 · FY2017 · MH
Rewiring cellular architecture to probe mechanical signal processing at kinetochores
$2,377,500Sophie Dumont · University Of California, San Francisco · DP2 · FY2015 · GM
Tracking tumor evolution through in vivo organelle profiling
$2,377,500Rushika Miriam Perera · University Of California, San Francisco · DP2 · FY2016 · CA
Decoding the fundamental mechanisms of tumor emergence and evolution
$2,377,500Carlos Carmona-Fontaine · New York University · DP2 · FY2019 · CA
Synaptic Reprogramming of Adult Neurons
$2,377,500Melanie A Samuel · Baylor College Of Medicine · DP2 · FY2016 · EY